Firocoxib
From Self-sufficiency
File:Firocoxib.svg | |
Systematic (IUPAC) name | |
---|---|
3-(Cyclopropylmethoxy)-5,5-dimethyl-4-(4-methylsulfonylphenyl)furan-2-one | |
Clinical data | |
Routes of administration | Oral |
Legal status | |
Legal status | |
Identifiers | |
CAS Number | 189954-96-9 |
ATCvet code | QM01AH90 (WHO) |
PubChem | CID 208910 |
Chemical data | |
Formula | C17H20O5S |
Molar mass | 336.402 g/mol[[Script error: No such module "String".]] |
Firocoxib (INN; brand names Equioxx and Previcox) is a non-steroidal anti-inflammatory drug of the COX-2 inhibitor (coxib) class, currently approved for use in dogs and horses. Firocoxib was the first COX-2 inhibitor approved by the U.S. Food and Drug Administration for horses.[1]
References
Cite error: Invalid <references>
tag;
parameter "group" is allowed only.
<references />
, or <references group="..." />
40x30px | This veterinary medicine–related article is a stub. You can help ssf by expanding it. |
- ↑ "New NSAID Equioxx (firocoxib) Approved by USEF". The Horse. July 2, 2007. Retrieved 2008-04-18.
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Articles containing unverified chemical infoboxes
- 2Fix
- Veterinary medicine stubs
- Dog health
- Equine medications
- Lactones
- Sulfones
- COX-2 inhibitors
- Furans
- Ethers